Green VIVO Community Engagement
Lobbying & Advocacy
We believe that cannabis can improve the lives of many more people. This drives our commitment for a world where patients have access to the products they need, without stigma or prosecution.
Our lobby and advocacy work in Europe is particularly based on six umbrella goals:
1.
Improved legal status for medical cannabis and safe access for patients in need.
2.
Consistent reimbursement and fair costs for prescribed cannabis medicine.
3.
Quality education and harmonized medical cannabis guidelines for health care professionals.
4.
Fair market access for licensed cannabis companies (single EU market rules).
5.
Enhanced public funding for cannabis research and evidence studies.
6.
Balanced presentation of risks and benefits of medical cannabis in public education.
Green VIVO is a Member of the European Cannabis Association
The ECA unites members of the industry, legal counsel and investors. The aim of the ECA is to represent the interests of the European cannabis industry in the international environment and vis-à-vis decision-makers in order to achieve an appropriate regulatory framework for the industry. To this end, the ECA’s working groups develop, among other things, guidelines, policies and codes of conduct related to quality, regulatory and compliance issues, and create a space for the discussion of new developments in these areas.
“Despite the rising significance of medical cannabis in the European economic discourse, a unified legal framework for its trade within the EU remains elusive. This gap is precisely what the ECA aims to address.”
Dr. Alex R. Martin, Chairperson, European Cannabis Association (ECA)
Working with the Ministry of Public Health (MOPH) in Thailand
Green Vivo has been closely following the development of cannabis production in Thailand and is in constant communication with the MOPH to ensure regulatory standards are being met for all procurement partners in our Portfolio. We provide advisory for implementation of policies affecting exporting of medical cannabis and social infrastructure policies such as decriminalization and control of recreational use.
Corporate Responsibility
“
Taking responsibility for good causes is the hallmark of any great business.
”
We support the dignity and well-being of our employees, the communities where we live and work, and those impacted by our operations. Our practices are based on the UN Guiding Principles on Business and Human Rights and aligned to UN Sustainable Development Goals.
We support leading experts in their fight for better systems, to help creating knowledge and evidence about the benefits of cannabis in modern medicine and society.
Sustainability
As a responsible employer, we respect and support the communities where we live and work, and those impacted by our operations, products and business relationships.
We pursue high standards in environmental conservation and climate protection. In our partners’ cultivation facilities, we ensure they rely on innovative water recovery systems and pesticide-free cultivation. This enables safe cannabis products and supports our high standards to protect nature and biodiversity.
Our engagement model
Bettering the state of the health systems across Europe in the interest of patients is a task that needs all our efforts focused – and one we cannot do alone.
Lobbying
We support politicians and governments in the development of policy frameworks for cannabis products. We monitor political debates to drive change.
Advocacy
Together with patient groups and experts, we are campaigning for more accessibility and against the stigmatisation of medical cannabis.
Sustainability
We pursue high standards in environmental conservation and climate protection.
Corporate Responsibility
We support breakthrough research in medicine, science and healthcare relevant to cannabis.
